HomeLAB • NASDAQ
Standard Biotools Inc
$1.15
0.88%
+0.010 Today
After Hours:
$1.12
(2.61%)-0.030
Closed: Mar 12, 8:00:00 PM GMT-4 · USD · NASDAQ · Disclaimer
Market news
Financials
Income Statement
-40M-20M020M40M
Revenue
Net Income
Revenue
Net income
(USD)Dec 2024Y/Y change
Revenue
46.72M65.74%
Operating expense
51.64M12.11%
Net income
-34.07M-72.29%
Net profit margin
-72.93-3.95%
Earnings per share
-0.0559.18%
EBITDA
-25.78M-86.83%
Effective tax rate
-0.80%
0200M400M600M
Total Assets
Total Liabilities
Total assets
Total liabilities
(USD)Dec 2024Y/Y change
Cash and short-term investments
292.87M154.91%
Total assets
612.34M89.54%
Total liabilities
140.62M-12.04%
Total equity
471.72M
Shares outstanding
374.54M
Price to book
0.90
Return on assets
-11.49%
Return on capital
-13.72%
0100M200M
Net Change in Cash
Net change in cash
(USD)Dec 2024Y/Y change
Net income
-34.07M-72.29%
Cash from operations
-14.06M0.01%
Cash from investing
25.73M296.13%
Cash from financing
-54.52M-5,335.69%
Net change in cash
-43.12M-54.27%
Free cash flow
797.00K161.24%
StockUS listed securityUS headquartered
Previous close
$1.14
Day range
$1.10 - $1.18
Year range
$0.99 - $3.04
Market cap
599.34M USD
Avg Volume
2.28M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
Standard BioTools Inc., previously known as Fluidigm Corp., is an American life science tools company that offers analytical mass cytometry systems for flow cytometry and tissue imaging, along with associated assays and reagents, as well as an automated genomic analysis instrument and a variety of microfluidic arrays, or integrated fluidic circuits, and consumables with fully kitted reagents. Custom assays and services are available with all systems and applications. Standard BioTools sells products to academic research institutions; translational research and medical centers; cancer centers; clinical research laboratories; biopharmaceutical, biotechnology and plant and animal research companies; and contract research organizations. Wikipedia
Founded
1999
Employees
537
Discover more
You may be interested in
This list is generated from recent searches, followed securities, and other activity. Learn more

All data and information is provided “as is” for personal informational purposes only, and is not intended to be financial advice nor is it for trading purposes or investment, tax, legal, accounting or other advice. Google is not an investment adviser nor is it a financial adviser and expresses no view, recommendation or opinion with respect to any of the companies included in this list or any securities issued by those companies. Please consult your broker or financial representative to verify pricing before executing any trades. Learn more
People also search for
Search
Clear search
Close search
Main menu
Google apps